The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?

Title
The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
Authors
Keywords
Multiple sclerosis, Drug development, Pharmaceutical industry, Simvastatin, Caldribine
Journal
Multiple Sclerosis and Related Disorders
Volume 4, Issue 1, Pages 3-5
Publisher
Elsevier BV
Online
2014-11-21
DOI
10.1016/j.msard.2014.11.005

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started